Titre :
  • Safety and efficacy of neratinib (HKI-272) plus vinorelbine in the treatment of patients with ErbB2-positive metastatic breast cancer pretreated with anti-HER2 therapy.
Auteur : Awada, Ahmad ; Dirix, L. ; Manso Sanchez, L ; Xu, B ; Luu, T ; Diéras, Véronique ; Hershman, D L ; Agrapart, V ; Ananthakrishnan, R ; Staroslawska, E
Informations sur la publication : Annals of oncology, 24, 1, (page 109-116)
Statut de publication : Publié, 2013-01
Sujet CREF : Cancérologie
Mots-clés : Breast cancer
HER2
Neratinib
Tyrosine kinase inhibitor
Vinorelbine
Mots-clés MeSH : Adult
Antineoplastic Combined Chemotherapy Protocols -- administration & dosage -- adverse effects -- therapeutic use
Breast Neoplasms -- drug therapy -- metabolism -- pathology
Female
Humans
Male
Middle Aged
Neoplasm Metastasis
Quinolines -- administration & dosage -- adverse effects -- therapeutic use
Receptor, ErbB-2 -- metabolism
Vinblastine -- administration & dosage -- adverse effects -- analogs & derivatives -- therapeutic use
Note : Journal Article
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:0923-7534 
info:doi/10.1093/annonc/mds284
info:pii/mds284
info:pmid/22967996